This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Salas, S. P. Articles by Rosso, P. Search for Related Content PubMed PubMed Citation Articles by Salas, S. P. Articles by Rosso, P.

(Hypertension. 1995;26:1019-1023.)
© 1995 American Heart Association, Inc.

Articles

Effects of Long-term Nitric Oxide Synthesis Inhibition on Plasma Volume Expansion and Fetal Growth in the Pregnant Rat

Sofía P. Salas; Fernando Altermatt; Mauricio Campos; Andrea Giacaman; Pedro Rosso

From the Departments of Obstetrics and Gynecology, Pediatrics, and Center for Medical Research, School of Medicine, Catholic University of Chile, Santiago.

Abstract We conducted the present study to investigate whether the vasodilator nitric oxide plays a role in plasma volume homeostasis during pregnancy. Pregnant Sprague-Dawley rats were randomly assigned to a control group (n=18) or to groups receiving 0.69 mmol/L (n=11) or 1.7 mmol/L (n=14) N-nitro-L-arginine, a competitive inhibitor of nitric oxide synthetase, from gestational days 7 through 21. On day 20 systolic pressure was measured. On day 21 blood samples were taken for plasma volume, hematocrit, and hormonal measurements. Fetal and placental weights also were determined. Systolic pressure was significantly higher in experimental rats (101±6 and 115±6 mm Hg in the 0.69 and 1.7 mmol/L groups, respectively) than in controls (79.7±7.5 mm Hg), and plasma volume was lower (18.4±1.1 and 17.1±0.5 mL) than in controls (21.5±0.8 mL). Both experimental groups had increased hematocrit levels. Plasma renin activity was significantly lower in the experimental groups (11.5±3 and 7.2±1.5 ng angiotensin I/mL per hour) than in controls (21.9±2.7 ng angiotensin I/mL per hour); however, no changes were observed in aldosterone levels. Experimental groups had lower fetal weight (4.6±0.1 and 5.1±0.1 g) than controls (5.5±0.1 g). In addition, fetal hindlimb hypoplasia was observed in the experimental groups. In conclusion, the present data indicate that long-term N-nitro-L-arginine administration to pregnant rats leads to increased blood pressure, reduced plasma volume expansion, lower plasma renin activity, and fetal growth retardation. These results suggest that nitric oxide may play an important role in maternal systemic vasodilatation and indirectly in plasma volume homeostasis and fetal growth.

Key Words: pregnancy • nitric oxide • aldosterone • renin • fetal growth retardation

This article has been cited by other articles:

				S. P. Salas, A. Giacaman, W. Romero, P. Downey, E. Aranda, D. Mezzano, and C. P. Vio Pregnant Rats Treated With a Serotonin Precursor Have Reduced Fetal Weight and Lower Plasma Volume and Kallikrein Levels Hypertension, October 1, 2007; 50(4): 773 - 779. [Abstract] [Full Text] [PDF]

				O. W.H. van der Heijden, Y. P.G. Essers, G. Fazzi, L. L.H. Peeters, J. G.R. De Mey, and G. J.J.M. van Eys Uterine Artery Remodeling and Reproductive Performance Are Impaired in Endothelial Nitric Oxide Synthase-Deficient Mice Biol Reprod, May 1, 2005; 72(5): 1161 - 1168. [Abstract] [Full Text] [PDF]

				S. P. Salas, A. Giacaman, and C. P. Vio Renal and Hormonal Effects of Water Deprivation in Late-Term Pregnant Rats Hypertension, September 1, 2004; 44(3): 334 - 339. [Abstract] [Full Text] [PDF]

				S. P. Salas, A. Giacaman, and C. P. Vio Pregnant Rats With 5/6 Nephrectomy Have Normal Volume Expansion Despite Lower Renin and Kallikrein Hypertension, October 1, 2003; 42(4): 744 - 748. [Abstract] [Full Text] [PDF]

				H. L. Galan, T. R. H. Regnault, T. D. Le Cras, R. W. Tyson, R. V. Anthony, R. B. Wilkening, and S. H. Abman Cotyledon and binucleate cell nitric oxide synthase expression in an ovine model of fetal growth restriction J Appl Physiol, June 1, 2001; 90(6): 2420 - 2426. [Abstract] [Full Text] [PDF]

				F. Lo and S. Kaufman Effect of 5{alpha}-pregnan-3{alpha}-ol-20-one on nitric oxide biosynthesis and plasma volume in rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1902 - R1905. [Abstract] [Full Text] [PDF]

				L. A. Hefler, C. A. Reyes, W. E. O'Brien, and A. R. Gregg Perinatal Development of Endothelial Nitric Oxide Synthase-Deficient Mice Biol Reprod, February 1, 2001; 64(2): 666 - 673. [Abstract] [Full Text]

				G. M. Tiboni and F. Giampietro Inhibition of nitric oxide synthesis causes preterm delivery in the mouse Hum. Reprod., August 1, 2000; 15(8): 1838 - 1842. [Abstract] [Full Text] [PDF]

				S. P. Salas, J. F. Vuletin, A. Giacaman, P. Rosso, and C. P. Vio Long-Term Nitric Oxide Synthase Inhibition in Rat Pregnancy Reduces Renal Kallikrein Hypertension, October 1, 1999; 34(4): 865 - 871. [Abstract] [Full Text] [PDF]

				A. Kurtz and C. Wagner Role of nitric oxide in the control of renin secretion Am J Physiol Renal Physiol, December 1, 1998; 275(6): F849 - F862. [Abstract] [Full Text] [PDF]

				S. L. Tam and S. Kaufman NOS inhibition restores renal responses to atrial distension during pregnancy Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1364 - R1367. [Abstract] [Full Text] [PDF]